NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Juro Sciences

Juro Sciences

Private
YokohamaHealthcare & Life Scienceshttps://www.sfgsci.com/

Last Round

Series B

Sep 4, 2025

Total Funding Raised

$11.03M

Company Overview

Juro Sciences is a biopharmaceutical company dedicated to developing innovative therapies for underactive bladder.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Drug Discovery

Business Model

B2B

Customer Profile

Revenue Share, Government Contracts

AI Layer

Non-AI

Keywords

underactive bladderUABtransdermal drug deliveryTDDSclinical stage biotechdrug patchdrug developmentacetylcholinesterase inhibitorbiopharmaceuticalfirst-in-class therapyurologyinvestigational drugexperimental drug

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Juro Sciences Comps

Public and private peers based on sector, stage, and business model.

Juro Sciences comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Juro Sciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BSep 4, 2025
GrantJun 17, 2024
Series AApr 8, 2024

Key People

Founding team and executive leadership

Hiroshi Nagabukuro

Chief Executive Officer

Executive Team

Akira Tanaka

Board Member, Chief Scientific Officer

Executive Team

Juro Sciences Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 17, 2024

    Received grant from Japan Agency for Medical Research and Development.

Juro Sciences Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Juro Sciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Juro Sciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersYokohama
Employee Range5
Year FoundedN/A
Last FundingSep 4, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.